|
Mr. Fleming has served as a director since December 2000. Mr. Fleming has been a General Partner at Oxford Bioscience Partners, an international venture capital firm specializing in life science technology based investments, since 1996, and has served as its Managing Partner since 2001. Prior to joining Oxford Bioscience Partners, he was a Founding General Partner of MVP Ventures in Boston, MA. Mr. Fleming has also co-founded Medica Venture Partners, a venture capital investment firm specializing in early-stage healthcare and biotechnology companies in Israel. Mr. Fleming is a co-founder and Chairman of the Board of Memory Pharmaceuticals (NASDAQ:MEMY). He is also Chairman of the Board of BioProcessors Corporation and is a director of several other private companies including Leerink Swann, a Boston based investment bank specializing in healthcare companies. Mr. Fleming holds a M.P.A. from Princeton University and a B.A. from the University of California, Berkeley. | 